LifeMD (LFMD) Capital Expenditures (2020 - 2025)

LifeMD has reported Capital Expenditures for 6 years, with the latest figure at $155454.0 in Q4 2025.

• For the quarter ending Q4 2025, Capital Expenditures rose 102.56% year-over-year to $155454.0; the trailing twelve-month figure through Dec 2025 stood at $1.9 million (up 27.83% YoY), and the FY2025 full-year result was $1.9 million, up 27.83% from the prior year.
• Capital Expenditures for Q4 2025 stood at $155454.0, down from $797258.0 in the prior quarter.
• The five-year high for Capital Expenditures was $8.1 million in Q4 2022, with the low at -$6.1 million in Q4 2024.
• Historically, Capital Expenditures has averaged $1.0 million across 5 years, with a median of $408822.5 in 2024.
• The largest YoY upside for Capital Expenditures was 13433.32% in 2022 against a maximum downside of 5562.28% in 2022.
• LifeMD's Capital Expenditures stood at -$61105.0 in 2021, then jumped by 13433.32% to $8.1 million in 2022, then plunged by 74.13% to $2.1 million in 2023, then slumped by 388.66% to -$6.1 million in 2024, then soared by 102.56% to $155454.0 in 2025.
• The last three Capital Expenditures figures came in at $155454.0 (Q4 2025), $797258.0 (Q3 2025), and $795745.0 (Q2 2025), per Business Quant data.